PVH Corp. reports today — Tuesday, June 3 — against a backdrop of rapidly accelerating short interest, a stock that has clawed back ground anyway, and a clear divergence between what bears are doing and what the borrow market is telling them.
Short sellers rebuilt positions at an unusually fast pace heading into the print. SI reached 10.2% of the free float on June 2 — up 18% over the week and back near the highs last seen in late April before a sustained four-week squeeze pushed it down toward 8.2%. That reversal is striking: bears who covered through most of May have returned in size, adding roughly 870,000 shares in just five days. The ORTEX short score climbed to 61.2 on June 2, up from 54.8 ten days earlier — a move that signals the conviction behind the re-entry.
The borrow market, though, is not sounding an alarm. Cost to borrow sits at just 0.50%, well below levels that would suggest crowding or stress in the lending pool. Availability runs at 218% — meaning there are roughly two shares available to borrow for every share already borrowed — and that ratio has tightened sharply from 345% a week ago. The direction of travel matters: availability has compressed by nearly 23% in seven days as fresh shorts have absorbed supply. If that pace continues through the next reporting cycle, the borrow picture will look meaningfully tighter. For now, the setup is short interest high and rebuilding, cost low, availability narrowing — a market that is building pressure but has not yet hit a constraint.
Options positioning leans defensively skewed, though not to an extreme. The put/call ratio has drifted down from around 3.87 in mid-May to 3.58 now, still well above the 52-week low of 0.34 and close to its 20-day average of 3.17. The z-score of 0.63 suggests the hedge book is elevated but not at a panic reading. What's notable in the history is a step-change: before May 15 the PCR was running around 2.45–2.50, then jumped to the high 3s — a shift in the options structure that has held for three weeks. That persistence, against a backdrop of a rising stock price, is worth flagging.
The analyst community is broadly constructive, and recent moves point toward higher targets. UBS lifted its price target to $130 from $120 last week — the most recent move — keeping its Buy rating. Goldman Sachs raised its target to $93 in early April, also maintaining Buy. With the stock at $97.21, those targets bracket the current price, but the consensus mean of $99.67 is only modestly above it. Needham sits further out at $107. Telsey Advisory holds a Market Perform with an $84 target, the outlier on the cautious side. Valuation looks undemanding: the trailing P/E sits around 7.6x and EV/EBITDA near 7.4x, both of which have edged higher over the past month as the stock has recovered. Price-to-book is below 1x at 0.80, reflecting the persistent discount the market has applied to the brand portfolio.
The bull case centres on Calvin Klein and Tommy Hilfiger sustaining full-price sell-through momentum and bottom-line expansion after a return to growth in FY26. Bulls point to cost discipline and marketing investment as proof of a durably improving model. FMR (Fidelity) stands as the largest holder at 14.4% of shares, having added a substantial 2.4 million shares in the period ending April 30 — the single biggest institutional move in the data. Bears cite weak traffic in Europe and the Americas, margin pressure from tariffs and promotional activity, and the declining smaller-brand portfolio. The insider picture is worth noting: CEO Stefan Larsson sold roughly $1.4 million of stock at $90.74 in mid-April. General Counsel Mark Fischer sold $642,000 across three transactions. The sales are modest relative to position sizes and coincided with the broader market recovery, but the clustering at the $90–$95 level is visible.
The last two confirmed earnings reactions point to sharp upside moves: a 10.5% next-day gain in April and a 15% surge in late March, with five-day moves of 25% and 24% respectively. Those reactions reflect a stock that had been heavily de-rated and snapped back hard when results arrived cleaner than feared. The setup now is different — the stock has already absorbed much of that recovery, sitting at $97, up 6% over the past month. What to watch is whether today's print can demonstrate that the top-line recovery is durable rather than cyclical, and whether management's commentary on tariff headwinds and European traffic shifts the market's read on the margin trajectory through the rest of the year.
See the live data behind this article on ORTEX.
Open PVH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
